Back
Novartis AG Vs. CRISPR Therapeutics AG Industry Stock Comparison
Buy
73
NVSEF
Novartis AG
Last Price:
109.26
Seasonality Move:
4.4%
Sell
50
CRSP
CRISPR Therapeutics AG
Last Price:
46.31
Seasonality Move:
35.78%
Buy
73
Novartis AG (NVSEF)
is a Buy
Is Novartis AG a Buy, Sell or Hold?
- The current Novartis AG [NVSEF] share price is $109.26. The Score for NVSEF is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
- NVSEF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
- The current CRISPR Therapeutics AG [CRSP] share price is $47.93. The Score for CRSP is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NVSEF Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $109.26
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVSEF is experiencing slight selling pressure.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $47.93
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRSP is experiencing selling pressure, which indicates risk of future bearish movement.
NVSEF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.79 | Sell |
| Relative Strength Index (14 RSI): | 43.85 | Sell |
| Chaikin Money Flow: | -10887 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (109.16 - 112.62) | Sell |
| Bollinger Bands (100): | (104.97 - 114.77) | Sell |
CRSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.35 | Buy |
| Relative Strength Index (14 RSI): | 51.23 | Buy |
| Chaikin Money Flow: | -822006 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.58 - 48.4) | Buy |
| Bollinger Bands (100): | (45.82 - 56.72) | Sell |
NVSEF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 110.4 | Sell |
| 20-day SMA: | 110.82 | Sell |
| 50-day SMA: | 113.27 | Sell |
| 200-day SMA: | 104.76 | Buy |
| 8-day EMA: | 109.95 | Sell |
| 20-day EMA: | 110.81 | Sell |
| 50-day EMA: | 111.23 | Sell |
| 200-day EMA: | 105.02 | Buy |
CRSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.05 | Sell |
| 20-day SMA: | 47.12 | Buy |
| 50-day SMA: | 47.2 | Buy |
| 200-day SMA: | 58.39 | Sell |
| 8-day EMA: | 48.14 | Sell |
| 20-day EMA: | 47.64 | Buy |
| 50-day EMA: | 48.2 | Sell |
| 200-day EMA: | 54.02 | Sell |
Novartis AG Earnings Growth & NVSEF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.17 per share, and a decrease next year of $0.00 per share.
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.69 per share, and an increase next year of $0.35 per share.
Novartis AG Technical Analysis
| Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CRISPR Therapeutics AG Technical Analysis
| Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||